Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Atazanavir 300mg / Cobicistat 150mg tablets |
BNF code | 0503010ALAAAAAA |
Virtual Therapeutic Moiety | Atazanavir + Cobicistat |
Basis of preferred name | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Cobicistat |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 150.000 |
Strength value numerator unit | mg |
Virtual Product Ingredient | |
Ingredient | Atazanavir sulfate |
Basis of pharmaceutical strength | Based on Base Substance |
Basis of strength substance identifier | 413592000 |
Strength value numerator | 300.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | tablet.oral |
Dose Form | |
Formulation | Oral tablet |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) | |
Virtual Medicinal Product Packs | |
Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.